The traditional, tumor-cytotoxic N1 phenotype has the potential to kill tumor cells, due to elevated levels of immune-activating factors (e.g., TNF-α, ICAM-1, FAS) [32] and direct antibody-dependent cytotoxicity [33,34]. The gene discussed is ICAM1; the disease is neoplasm.